Quality of Life Trajectory and Its Mediators in Older Patients With Acute Decompensated Heart Failure Receiving a Multi-Domain Rehabilitation Intervention: Results From the Rehabilitation Therapy in Older Acute Heart Failure Patients Trial

Author:

Whellan David1ORCID,McCarey Melissa M.2ORCID,Chen Haiying3,Nelson M. Benjamin4,Pastva Amy M.5ORCID,Duncan Pamela6ORCID,Mentz Robert J.7ORCID,Kitzman Dalane W.48,Reeves Gordon9,Reed Shelby D.10ORCID

Affiliation:

1. Department of Medicine, Sidney Kimmel Medical College (D.W.), Thomas Jefferson University, Philadelphia, PA.

2. Jefferson Clinical Research Institute (M.M.M.), Thomas Jefferson University, Philadelphia, PA.

3. Department of Biostatistics and Data Science (H.C.), Wake Forest School of Medicine, Winston-Salem, NC.

4. Section on Cardiovascular Medicine, Department of Internal Medicine (M.B.N., D.W.K.), Wake Forest School of Medicine, Winston-Salem, NC.

5. Doctor of Physical Therapy Division, Department of Orthopaedic Surgery (A.M.P.), Duke University School of Medicine, Durham, NC.

6. Department of Neurology (P.D.), Wake Forest School of Medicine, Winston-Salem, NC.

7. Division of Cardiology and Duke Clinical Research Institute (R.J.M.), Duke University School of Medicine, Durham, NC.

8. Section on Geriatrics, Department of Internal Medicine (D.W.K.), Wake Forest School of Medicine, Winston-Salem, NC.

9. Novant Health Heart and Vascular Institute, Charlotte, NC (G.R.).

10. Department of Population Health Sciences (S.D.R.), Duke University School of Medicine, Durham, NC.

Abstract

Background: As patients with heart failure experience worsening of their condition, including acute decompensated heart failure, quality of life deteriorates. However, the trajectory of quality of life changes and their determinants in the context of the Rehabilitation Therapy in Older Acute Heart Failure Patients trial physical rehabilitation intervention are unknown. Methods: Patients ≥60 years old admitted for acute decompensated heart failure (n=349) were randomized to either attention control or intervention. Quality of life outcomes (Kansas City Cardiomyopathy Questionnaire; 12-Item Short-Form Health Survey) were measured at baseline (inpatient), 1 month, and 3 months. Intervention effects were assessed using linear mixed effects regression, including covariates to model the main effects of the intervention and timing of outcome assessments. Mediation analysis determined if changes in Kansas City Cardiomyopathy Questionnaire were due to improvement in physical function (short physical performance battery, 6-minute walk distance). Results: Baseline Kansas City Cardiomyopathy Questionnaire summary score was similarly poor in the intervention and control arms (40.2±20.6 versus 41.5±20.6). Although the intervention experienced nominally greater Kansas City Cardiomyopathy Questionnaire improvement than control at 1 month (64.7±1.9 versus 61.1±1.9, P =0.13), the difference was not statistically significant until 3 months (67.7±1.9 versus 60.8±1.9, P =0.004). Twelve-Item Short-Form Health Survey Physical and Mental Composite Scores increased in both arms at 1 month and continued improvement only in the intervention. The 3-month improvement in short physical performance battery score explained 64.1% of the improvement in Kansas City Cardiomyopathy Questionnaire ( P <0.001). Conclusions: In older patients hospitalized for acute decompensated heart failure, quality of life improves in the first month after discharge. The quality of life benefit of a post-discharge physical rehabilitation intervention is detected early with large significant improvements at 3 months achieved primarily through improvement in short physical performance battery. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT02196038.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables

2. Center for Clinical Standards and Quality. In: Services CfMM, ed. CMS Quality Measure Development Plan 2020 Annual Report for the Quality Payment Program. CMS; 2020.

3. U.S. Food and Drug Administration. Draft Guidance Document Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry. USFDA; 2019. Accessed March 25 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/treatment-heart-failure-endpoints-drug-development-guidance-industry.

4. U.S. Food and Drug Administration. DDT COA #000084: Kansas City Cardiomyopathy Questionnaire (KCCQ). Accessed March 25 2021. https://www.fda.gov/drugs/clinical-outcome-assessment-coa-qualification-program/ddt-coa-000084-kansas-city-cardiomyopathy-questionnaire-kccq.

5. A Novel Rehabilitation Intervention for Older Patients With Acute Decompensated Heart Failure

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3